Shivam A Shah1, Ioannis Kormpakis, Necat Havlioglu, Michael S Ominsky, Leesa M Galatz, Stavros Thomopoulos. 1. 1Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, Missouri 2Department of Pathology, John Cochran VA Medical Center, St. Louis, Missouri 3Metabolic Disorders Research, Amgen, Inc., Thousand Oaks, California 4Department of Orthopedic Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY 5Department of Orthopedic Surgery, Department of Biomedical Engineering, Columbia University, New York, NY.
Abstract
BACKGROUND: Rotator cuff tears are a common source of pain and disability, and poor healing after repair leads to high retear rates. Bone loss in the humeral head before and after repair has been associated with poor healing. The purpose of the current study was to mitigate bone loss near the repaired cuff and improve healing outcomes. METHODS: Sclerostin antibody (Scl-Ab) treatment, previously shown to increase bone formation and strength in the setting of osteoporosis, was used in the current study to address bone loss and enhance rotator cuff healing in an animal model. Scl-Ab was administered subcutaneously at the time of rotator cuff repair and every 2 weeks until the animals were sacrificed. The effect of Scl-Ab treatment was evaluated after 2, 4, and 8 weeks of healing, using bone morphometric analysis, biomechanical evaluation, histological analysis, and gene expression outcomes. RESULTS: Injury and repair led to a reduction in bone mineral density after 2 and 4 weeks of healing in the control and Scl-Ab treatment groups. After 8 weeks of healing, animals receiving Scl-Ab treatment had 30% greater bone mineral density than the controls. A decrease in biomechanical properties was observed in both groups after 4 weeks of healing compared with healthy tendon-to-bone attachments. After 8 weeks of healing, Scl-Ab-treated animals had improved strength (38%) and stiffness (43%) compared with control animals. Histological assessment showed that Scl-Ab promoted better integration of tendon and bone by 8 weeks of healing. Scl-Ab had significant effects on gene expression in bone, indicative of enhanced bone formation, and no effect on the expression of genes in tendon. CONCLUSIONS: This study provides evidence that Scl-Ab treatment improves tendon-to-bone healing at the rotator cuff by increasing attachment-site bone mineral density, leading to improved biomechanical properties. CLINICAL RELEVANCE: Scl-Ab treatment may improve outcomes after rotator cuff repair.
BACKGROUND: Rotator cuff tears are a common source of pain and disability, and poor healing after repair leads to high retear rates. Bone loss in the humeral head before and after repair has been associated with poor healing. The purpose of the current study was to mitigate bone loss near the repaired cuff and improve healing outcomes. METHODS: Sclerostin antibody (Scl-Ab) treatment, previously shown to increase bone formation and strength in the setting of osteoporosis, was used in the current study to address bone loss and enhance rotator cuff healing in an animal model. Scl-Ab was administered subcutaneously at the time of rotator cuff repair and every 2 weeks until the animals were sacrificed. The effect of Scl-Ab treatment was evaluated after 2, 4, and 8 weeks of healing, using bone morphometric analysis, biomechanical evaluation, histological analysis, and gene expression outcomes. RESULTS: Injury and repair led to a reduction in bone mineral density after 2 and 4 weeks of healing in the control and Scl-Ab treatment groups. After 8 weeks of healing, animals receiving Scl-Ab treatment had 30% greater bone mineral density than the controls. A decrease in biomechanical properties was observed in both groups after 4 weeks of healing compared with healthy tendon-to-bone attachments. After 8 weeks of healing, Scl-Ab-treated animals had improved strength (38%) and stiffness (43%) compared with control animals. Histological assessment showed that Scl-Ab promoted better integration of tendon and bone by 8 weeks of healing. Scl-Ab had significant effects on gene expression in bone, indicative of enhanced bone formation, and no effect on the expression of genes in tendon. CONCLUSIONS: This study provides evidence that Scl-Ab treatment improves tendon-to-bone healing at the rotator cuff by increasing attachment-site bone mineral density, leading to improved biomechanical properties. CLINICAL RELEVANCE: Scl-Ab treatment may improve outcomes after rotator cuff repair.
Authors: Leesa M Galatz; Craig M Ball; Sharlene A Teefey; William D Middleton; Ken Yamaguchi Journal: J Bone Joint Surg Am Date: 2004-02 Impact factor: 5.284
Authors: Michael S Ominsky; Fay Vlasseros; Jacquelin Jolette; Susan Y Smith; Brian Stouch; George Doellgast; Jianhua Gong; Yongming Gao; Jin Cao; Kevin Graham; Barbara Tipton; Jill Cai; Rohini Deshpande; Lei Zhou; Michael D Hale; Daniel J Lightwood; Alistair J Henry; Andrew G Popplewell; Adrian R Moore; Martyn K Robinson; David L Lacey; W Scott Simonet; Chris Paszty Journal: J Bone Miner Res Date: 2010-05 Impact factor: 6.741
Authors: Megan L Killian; Leonardo M Cavinatto; Samuel R Ward; Necat Havlioglu; Stavros Thomopoulos; Leesa M Galatz Journal: Am J Sports Med Date: 2015-08-21 Impact factor: 6.202
Authors: Alexis Chiang Colvin; Natalia Egorova; Alicia K Harrison; Alan Moskowitz; Evan L Flatow Journal: J Bone Joint Surg Am Date: 2012-02-01 Impact factor: 5.284
Authors: Xiaodong Li; Michael S Ominsky; Kelly S Warmington; Sean Morony; Jianhua Gong; Jin Cao; Yongming Gao; Victoria Shalhoub; Barbara Tipton; Raj Haldankar; Qing Chen; Aaron Winters; Tom Boone; Zhaopo Geng; Qing-Tian Niu; Hua Zhu Ke; Paul J Kostenuik; W Scott Simonet; David L Lacey; Chris Paszty Journal: J Bone Miner Res Date: 2009-04 Impact factor: 6.741
Authors: Edwin R Cadet; George C Vorys; Ra'Kerry Rahman; Sang-Hyun Park; Thomas R Gardner; Francis Y Lee; William N Levine; Louis U Bigliani; Christopher S Ahmad Journal: J Orthop Res Date: 2010-03 Impact factor: 3.494
Authors: Amanda L Scheiber; David K Barton; Basma M Khoury; Joan C Marini; Donald L Swiderski; Michelle S Caird; Kenneth M Kozloff Journal: J Bone Miner Res Date: 2019-11-07 Impact factor: 6.741
Authors: Elisabeth A Lemmon; Ryan C Locke; Adrianna K Szostek; Elahe Ganji; Megan L Killian Journal: Connect Tissue Res Date: 2018-07-02 Impact factor: 3.417
Authors: Xaver Feichtinger; Patrick Heimel; Claudia Keibl; David Hercher; Jakob Emanuel Schanda; Roland Kocijan; Heinz Redl; Johannes Grillari; Christian Fialka; Rainer Mittermayr Journal: J Orthop Surg Res Date: 2021-04-13 Impact factor: 2.359